- CIMBA+
- CIMBA+ is planning to collect data, and later germline DNA, on pathogenic and likely pathogenic PALB2, ATM, CHEK2, RAD51C, RAD51D, BARD1, BRIP1, TP53, CDH1, PTEN, MSH6, FANCM and STK11 female and male mutation carriers.
- Genotyping (GWAS)
Centre For Cancer Genetic Epidemiology